Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease

被引:68
作者
Bridi, R [1 ]
Araldi, J [1 ]
Sgarbi, MB [1 ]
Testa, CG [1 ]
Durigon, K [1 ]
Wajner, M [1 ]
Dutra-Filho, CS [1 ]
机构
[1] Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, BR-90035003 Porto Alegre, RS, Brazil
关键词
maple syrup urine disease; leucine; isoleucine; valine; oxidative stress; free radicals; antioxidant brain defenses;
D O I
10.1016/S0736-5748(03)00074-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Maple syrup urine disease (MSUD) is an inherited disorder caused by deficiency of branched-chain L-2-keto acid dehydrogenase complex activity. Affected patients present severe brain dysfunction manifested as convulsions, coma, psychomotor delay and mental retardation. However, the underlying mechanisms of these neurological findings are virtually unknown. In this study, we tested the in vitro effect of L-leucine, L-isoleucine and L-valine, the amino acids accumulating in MSUD, on the lipid peroxidation parameters chemiluminescence and thiobarbituric acid-reactive substances (TBA-RS), as well as on total radical-trapping antioxidant potential (TRAP) and total antioxidant reactivity (TAR) in cerebral cortex from 30-day-old rats. L-Leucine significantly increased chemiluminescence and TBA-RS measurements and markedly decreased TRAP and TAR values. L-Isoleucine increased chemiluminescence and decreased TRAP measurements, but TAR and TBA-RS levels were not altered by the amino acid. Finally, TRAP measurement was diminished by L-valine. The results indicate a stimulation of lipid peroxidation and a reduction of brain capacity to efficiently modulate the damage associated with an increased production of free radicals by the branched-chain amino acids (BCAAs) accumulated in MSUD. It is therefore tempting to speculate that oxidative stress may be implicated in the brain damage found in MSUD patients. (C) 2003 ISDN. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 42 条
  • [1] Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats
    Araújo, P
    Wassermann, GF
    Tallini, K
    Furlanetto, V
    Vargas, CR
    Wannmacher, CMD
    Dutra, CS
    Wyse, ATS
    Wajner, M
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2001, 38 (06) : 529 - 537
  • [2] BREMER HJ, 1981, DISTURBANCES AMINO A, P359
  • [3] Chuang DT., 2001, The metabolic and molecular bases of inherited disease, P1971
  • [4] STUDIES ON LIPID-PEROXIDATION IN THE RAT-BRAIN
    CINI, M
    FARIELLO, RG
    BIANCHETTI, A
    MORETTI, A
    [J]. NEUROCHEMICAL RESEARCH, 1994, 19 (03) : 283 - 288
  • [5] Glutamate uptake
    Danbolt, NC
    [J]. PROGRESS IN NEUROBIOLOGY, 2001, 65 (01) : 1 - 105
  • [6] DANNER DJ, 1989, METABOLIC BASIS INHE, P671
  • [7] GLUTAMATE AND GAMMA-AMINOBUTYRIC-ACID NEUROTRANSMITTER SYSTEMS IN THE ACUTE PHASE OF MAPLE SYRUP URINE DISEASE AND CITRULLINEMIA ENCEPHALOPATHIES IN NEWBORN CALVES
    DODD, PR
    WILLIAMS, SH
    GUNDLACH, AL
    HARPER, PAW
    HEALY, PJ
    DENNIS, JA
    JOHNSTON, GAR
    [J]. JOURNAL OF NEUROCHEMISTRY, 1992, 59 (02) : 582 - 590
  • [8] ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
  • [9] Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols
    Evelson, P
    Travacio, M
    Repetto, M
    Escobar, J
    Llesuy, S
    Lissi, EA
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 388 (02) : 261 - 266
  • [10] Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease
    Fontella, FU
    Gassen, E
    Pulrolnik, V
    Wannmacher, CMD
    Klein, AB
    Wajner, M
    Dutra, CS
    [J]. METABOLIC BRAIN DISEASE, 2002, 17 (01) : 47 - 54